*Prices reflect U.S. average retail price
ASPIRIN; OMEPRAZOLE is used in people who have had heart problems or strokes caused by blood clots to help reduce their risk of further heart problems or strokes and in people who are at risk of developing stomach ulcers with aspirin.
Manufacturer's Website: Yosprala Average retail cost: $2,349/month
Durlaza is part of the NSAIDs class and treats Coronary Artery Disease, Heart Attack, and Stroke Risk Reduction. NSAIDs are used to treat fever, rheumatoid arthritis, osteoarthritis, menstrual pain, migraine, eye inflammation, allergic conjunctivitis, and other types of pain and inflammation.
Manufacturer's Website: Not Available Average retail cost: $226/month
Plavix (clopidogrel)
Clopidogrel, sold under the brand name Plavix among others, is an antiplatelet medication used to reduce the risk of heart disease and stroke in those at high risk. It is also used together with aspirin in heart attacks and following the placement of a coronary artery stent (dual antiplatelet therapy).....Wikipedia
Manufacturer's Website: Not Available Average retail cost: $288/month
Brilinta (ticagrelor)
Ticagrelor, sold under the brand name Brilinta among others, is a medication used for the prevention of stroke, heart attack and other events in people with acute coronary syndrome, meaning problems with blood supply in the coronary arteries....Wikipedia
Manufacturer's Website: Brilinta Average retail cost: $557/month
Prasugrel, sold under the brand name Effient in the US, Australia and India, and Efient in the EU) is a medication used to prevent formation of blood clots... Wikipedia
Manufacturer's Website: Not Available Average retail cost: $615/month
Prasugrel, sold under the brand name Effient in the US, Australia and India, and Efient in the EU) is a medication used to prevent formation of blood clots... Wikipedia
Manufacturer's Website: Cablivi Average retail cost: *
*This drug is only available at select specialty pharmacies, which usually means it may be expensive.
Kengreal (cangrelor)
Cangrelor, sold under the brand name Kengreal in the United States and Kengrexal in the European Union) is a P2Y12 inhibitor FDA approved as of June 2015 as an antiplatelet drug for intravenous application....Wikipedia
Manufacturer's Website: Kengreal Average retail cost: *
*This drug is administered by your healthcare practitioner, which usually means it may be expensive.